FDA Inspection
Baxter Healthcare Pty LtdBaxter Healthcare Pty Ltd – FDA Inspection, Jul 5, 2022
Record Details
This FDA Inspection record concerns Baxter Healthcare Pty Ltd, with an inspection on July 5, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Baxter Healthcare Pty Ltd
- Inspection Date
- July 5, 2022
- Product Type
- Drugs
View Company Profile
ID · f05e11f0-7d11-461f-ab82-1eeac12739ce
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1173554
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.113(b)Procedures for sterile drug products
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Baxter Healthcare Pty Ltd
1| Date | Classification | Office | Project area |
|---|---|---|---|
| April 9, 2019 | VAI | Office of Inspections and Investigations | New Drug Evaluation |
Other documents for Baxter Healthcare Pty Ltd
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.